down arrow

P & G Health Ltd

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE199A01012
  • NSEID: PGHL
  • BSEID: 500126
INR
5,222.95
35.45 (0.68%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 2.15 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Rs cr
Standalone Quarterly Results
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Sep'23
Jun'23
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2024 is -0.06% vs 0.00% in Dec 2023

stock-summary

Standalone Net Profit

YoY Growth in quarter ended Dec 2024 is 26.13% vs -6.16% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2024 is 21.43% vs -6.62% in Dec 2023

stock-summary

Interest

YoY Growth in quarter ended Dec 2024 is -21.05% vs -17.39% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2024 has improved from Dec 2023

Compare Quarterly Results Of P & G Health Ltd With
Markets Mojo
Figures in Rs cr
Standalone Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
309.77
2,396.57
-2,086.80
-87.07%
Other Operating Income
0.00
0.00
0.00
Total Operating income
309.77
2,396.57
-2,086.80
-87.07%
Raw Material Cost
61.60
179.72
-118.12
-65.72%
Purchase of Finished goods
13.28
445.60
-432.32
-97.02%
(Increase) / Decrease In Stocks
0.85
34.08
-33.23
-97.51%
Employee Cost
47.05
521.79
-474.74
-90.98%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
63.56
474.45
-410.89
-86.60%
Total Expenditure (Excl Depreciation)
186.34
1,655.64
-1,469.30
-88.75%
Operating Profit (PBDIT) excl Other Income
123.43
740.93
-617.50
-83.34%
Other Income
3.96
69.82
-65.86
-94.33%
Operating Profit (PBDIT)
127.39
810.75
-683.36
-84.29%
Interest
0.15
199.47
-199.32
-99.92%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
127.24
611.28
-484.04
-79.18%
Depreciation
5.55
87.03
-81.48
-93.62%
Profit Before Tax
121.69
524.25
-402.56
-76.79%
Tax
30.79
107.87
-77.08
-71.46%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
90.90
416.38
-325.48
-78.17%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
90.90
416.38
-325.48
-78.17%
Equity Capital
16.60
40.06
-23.46
-58.56%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
54.76
10.39
44.37
427.05%
Diluted Earnings per share
54.76
10.33
44.43
430.11%
Operating Profit Margin (Excl OI)
39.85%
30.92%
0.00
8.93%
Gross Profit Margin
41.08%
25.51%
0.00
15.57%
PAT Margin
29.34%
17.37%
0.00
11.97%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 309.77 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is -1.16% vs 10.40% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is -0.06% vs 0.00% in Dec 2023

Quarterly - Standalone Net Profit
Standalone Net Profit 90.90 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is 10.41% vs 390.64% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 26.13% vs -6.16% in Dec 2023

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 123.43 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is 8.23% vs 136.35% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 21.43% vs -6.62% in Dec 2023

Quarterly - Interest
Interest 0.15 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is 0.00% vs -25.00% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is -21.05% vs -17.39% in Dec 2023

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 39.85%
in Dec 2024

Figures in Rs %
stock-summary

QoQ Growth in quarter ended Dec 2024 has improved from Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 has improved from Dec 2023